4-[(tert-butylamino)methyl]-1-(4-chlorophenyl)-3-ethoxycarbonyl-5-(4-nitrophenyl)-1H-pyrazole chloride

ID: ALA4740598

PubChem CID: 162645171

Max Phase: Preclinical

Molecular Formula: C23H26Cl2N4O4

Molecular Weight: 456.93

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1nn(-c2ccc(Cl)cc2)c(-c2ccc([N+](=O)[O-])cc2)c1CNC(C)(C)C.Cl

Standard InChI:  InChI=1S/C23H25ClN4O4.ClH/c1-5-32-22(29)20-19(14-25-23(2,3)4)21(15-6-10-18(11-7-15)28(30)31)27(26-20)17-12-8-16(24)9-13-17;/h6-13,25H,5,14H2,1-4H3;1H

Standard InChI Key:  DSAKHHBKXBHKFO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 34  0  0  0  0  0  0  0  0999 V2000
   21.4643  -27.1678    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   18.8187  -27.7302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0353  -28.5301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6198  -27.9425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5379  -32.2713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5368  -33.0986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2515  -33.5114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9679  -33.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9650  -32.2677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2496  -31.8586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2515  -31.0379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9183  -30.5520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.6609  -29.7672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8349  -29.7709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5845  -30.5580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8050  -30.8190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1891  -30.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4066  -30.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2388  -31.3358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8597  -31.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6399  -31.6239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1433  -29.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9641  -29.1812    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4465  -28.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2672  -28.5954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8050  -28.3457    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3464  -29.1062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5265  -29.1969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2181  -28.6228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2513  -34.3363    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   17.4534  -31.6013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8367  -31.0533    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2873  -32.4092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  3  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 12 13  2  0
 11 12  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 10 11  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 15 16  1  0
 13 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 22 26  2  0
 14 27  1  0
 27 28  1  0
 28  3  1  0
  3 29  1  0
  7 30  1  0
 31 32  1  0
 31 33  2  0
 19 31  1  0
M  CHG  2  31   1  32  -1
M  END

Associated Targets(Human)

U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.93Molecular Weight (Monoisotopic): 456.1564AlogP: 5.17#Rotatable Bonds: 7
Polar Surface Area: 99.29Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.47CX LogP: 5.33CX LogD: 4.23
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.30Np Likeness Score: -1.42

References

1. da Silva MJV,Jacomini AP,Figueiredo MC,Back DF,Foglio MA,Ruiz ALTG,Paula FR,Rosa FA.  (2021)  Efficient synthesis and antitumor evaluation of 4-aminomethyl-N-arylpyrazoles: Discovery of potent and selective agents for ovarian cancer.,  29  [PMID:33214037] [10.1016/j.bmc.2020.115835]

Source